Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.33 |
| ▸ | CHAT | P28329 | 4/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13815207 | 0.89 | FUT8 (0.32) | FUT8CAMK2D | |
| SCHEMBL12173072 | 0.89 | MAPT (0.34) | FUT8CHATENPP3ENPP1CAMK2D | |
| SCHEMBL13763511 | 0.87 | CAMK2D (0.31) | FUT8CAMK2D | |
| SCHEMBL20390575 | 0.85 | FUT8 (0.40) | FUT8P2RX3CHATUSP2APEX1 | |
| SCHEMBL13764095 | 0.83 | FUT8 (0.38) | FUT8P2RX3CHATUSP2APEX1 | |
| SCHEMBL12053415 | 0.81 | FUT8 (0.38) | FUT8P2RX3CHATUSP2APEX1 | |
| SCHEMBL16626829 | 0.81 | FUT8 (0.40) | FUT8CHATUSP2APEX1ENPP3 | |
| SCHEMBL12173082 | 0.80 | FUT8 (0.38) | FUT8CHATUSP2APEX1ENPP3 | |
| SCHEMBL12646575 | 0.80 | FUT8 (0.38) | FUT8CHATUSP2APEX1ENPP3 | |
| SCHEMBL13715876 | 0.78 | CA12 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| US-7543926-B2 | Process for printing textile fibre materials in accordance with the ink-jet printing process | HUNTSMAN INTERNATIONAL LLC (US) | 2009-06-09 | — | — | US | disclosed |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| WO-2007063024-A2 | KERATIN-BINDING EFFECTOR MOLECULES CONTAINING REACTIVE DYES | BASF SE (DE) | 2007-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | KRT18, KLK3, KLKB1 | FUT8 2015/4885P2RX3 4717/4885CHAT 4242/4885 |
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | FUT8 769/4885P2RX3 2126/4885CHAT 1302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.